Market movers: Stocks seeing action on Tuesday - and why

  • 📰 globeandmail
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 92%

Business News News

Business Business Latest News,Business Business Headlines

A look at North American equities heading in both directions

and saying its shares face 35-50-per-cent long-term downside risk

It is also exploring strategic options for its consumer platform business, which has lost about US$3-billion in three years, executives told investors in February. Goldman’s profit in the quarter ended Mar. 31 fell to US$3.09-billion compared with US$3.83-billion a year earlier, while earnings per share slid to US$8.79 from US$10.76 last year, it said on Tuesday.

was down as it beat first-quarter profit estimates on Tuesday, benefiting from the Federal Reserve’s rate hikes that boosted the lender’s interest income. The New York-based lender’s net interest income for the quarter surged 62 per cent to US$1.1-billion, compared with US$698-million a year earlier.

Sales of its cancer treatments such as prostate cancer therapy Erleada and multiple myeloma drug Darzalex are closely watched by investors as the company targets about US$60-billion in drug sales by 2025 at a time when older drugs face fierce competition.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 5. in BUSİNESS

Business Business Latest News, Business Business Headlines